Refine your search
Collections
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Shyam Sundar, P.
- Discovery of Immunomodulators from Plant Kingdom Targeting IL-6 for the Effective Management Therapy of SARS-CoV-2
Abstract Views :163 |
PDF Views:92
Authors
Akey Krishna Swaroop
1,
Palathoti Nagarjuna
1,
P. Naresh
1,
P. Shyam Sundar
1,
S. Jubie
1,
Jawahar Natarajan
2,
P. Vasanth
3
Affiliations
1 Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
2 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
3 Department of Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
1 Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
2 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
3 Department of Biotechnology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, The Nilgiris – 643001, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 22, No 2 (2022), Pagination: 249 - 260Abstract
The present study was conducted because of the recent scenario of this pandemic coronavirus outbreak worldwide. Currently, this disease cannot be treated through specific vaccines and therapeutic medicines. While many vaccines are being investigated, it would take some time for these to be accessible to the masses. Eventual evidence indicates that many COVID-19 patients may die from an irregular release of cytokines called as Cytokine Release Syndrome (CRS) due to the excessive reaction of their immune systems. In worsening patients with COVID-19, CRS played a significant role, from pneumonia via ARDS to cumulative systemic inflammation and eventually to a failing of the multi-system organ. In COVID-19 individuals, a large number of cytokines, including IL-6, IL-1, IL-2, IL-10, TNF- α, and IFN- α, participate in the ‘cytokine storm,’ but IL-6, whose higher serum levels are associated with respiratory failure, ARDS, and adverse clinical outcomes, tends to be a critical factor. In China, the COVID-19 mortality indicator has been tested by a multi-centre retrospective analysis in 150 COVID-19 patients. The study analysed that 82 cases are resolved from COVID-19 and 68 cases are dead due to enhancement of IL-6 levels in the serum. In this research, the secondary plant metabolites from Indian traditional medicine are identified through a computational technique and the selected seedling metabolite is sealed to block the IL-6 receptor.Keywords
Covid-19, IL-6, Cytokine Release Syndrome, Secondary MetabolitesFull Text
References
- Abbasifard M, Khorramdelazad H. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics. Life Sci. 2020; 257. https://doi.org/10.1016/j.lfs.2020.118097. PMid:32679148. PMCid:PMC7361088
- Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: The Current evidence and treatment strategies. Front Immunol. 2020; 11(July):1–13. https:// doi.org/10.3389/fimmu.2020.01708. PMid:32754163. PMCid:PMC7365923
- Rana MM. Cytokine storm in COVID-19: Potential therapeutics for immunomodulation. J Res Clin Med. 2020; 8(1):38. https://doi.org/10.34172/jrcm.2020.038
- Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954. https://doi. org/10.1016/j.ijantimicag.2020.105954. PMid:32234467. PMCid:PMC7118634
- Sinha P, Matthay MA, Calfee CS. Is a “Cytokine Storm” relevant to COVID-19? JAMA Intern Med. 2020; 180(9):1152. https://doi.org/10.1001/jamainternmed.2020.3313. PMid:32602883.
- Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 2020; 111:102452. https://doi.org/10.1016/j. jaut.2020.102452. PMid:32291137. PMCid:PMC7151347
- Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020; 9(1):1123–30. https://doi.org/10.1080/222217 51.2020.1770129. PMid:32475230. PMCid:PMC7473317
- Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020; 146(3):518–34. https://doi.org/10.1016/j. jaci.2020.07.001. PMid:32896310. PMCid:PMC7471766
- Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL6) level in critically ill COVID-19 patients. Clin Infect Dis. 2020. https://doi.org/10.1101/2020.02.29.20029520
- Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome. Eur Respir J. 2020; 56(4). https://doi.org/10.1183/13993003.03006-2020. PMid:32883678. PMCid:PMC7474149
- Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020; 53:13–24. https:// doi.org/10.1016/j.cytogfr.2020.05.009. PMid:32475759. PMCid:PMC7237916
- Rees C, Costin J, Fink R, Mcmichael M, Fontaine K, Isern S, et al. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries. Antivir. Res. 2008; 80(2):135–42. https://doi. org/10.1016/j.antiviral.2008.05.007. PMid:18606464
- Berman HM, Kleywegt GJ, Nakamura H, Markley JL. The protein data bank archive as an open data resource. J Comput Aided Mol Des. 2014; 28(10):1009–14. https:// doi.org/10.1007/s10822-014-9770-y. PMid:25062767. PMCid:PMC4196035
- Alhazmi HA, Najmi A, Javed SA, Sultana S, Al Bratty M, Makeen HA, et al. Medicinal plants and isolated molecules demonstrating immunomodulation activity as potential alternative therapies for viral diseases including COVID19. Front Immunol. 2021; 12:1721. https://doi.org/10.3389/ fimmu.2021.637553. PMid:34054806. PMCid:PMC8155592
- Wagner H. Immunomodulatory agents from plants. Part of the Progress in Inflammation Research book series (PIR). Springer Science & Business Media; 1999. https://doi. org/10.1007/978-3-0348-8763-2
- Dahanukar SA, Thatte UM. Current status of Ayurveda in phytomedicine. Phytomedicine. 1997; 4(4):359–68. https:// doi.org/10.1016/S0944-7113(97)80048-7
- Dorsch W, Stuppner H, Wagner H, Gropp M, Demoulin S, Ring J. Antiasthmatic effects of Picrorhiza kurroa: Androsin prevents allergen-and PAF-induced bronchial obstruction in guinea pigs. Int Arch Allergy Immunol. 1991; 95(2–3):128–33. https://doi.org/10.1159/000235416. PMid:1718906
- Jantan I, Ahmad W, Bukhari SNA. Plant-derived immunomodulators: An insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015; 6:655. https:// doi.org/10.3389/fpls.2015.00655. PMid:26379683 PMCid:PMC4548092
- Nair A, Chattopadhyay D, Saha B. Plant-derived immunomodulators. In: New look to phytomedicine. Elsevier; 2019. p. 435–99. https://doi.org/10.1016/B978-0-12-814619- 4.00018-5. PMid:30794457
- Swaroop AK, Mvnl C, S M, Subramanian G, Natarajan J, Selvaraj J. Plant derived immunomodulators: A Critical Review [Internet]. 2021. [cited 2021 Nov 9]. Available from: https://apb.tbzmed.ac.ir/Article/apb-32199. https://doi. org/10.34172/apb.2022.074
- Akey KS, Jubie S, Vasanth P, Jeyaprakash M, Jawahar N. Dual modulation of IL-6 pathway by flavonoid-metal complexes as immune boosters for SARS-CoV-2 therapy. SPAST Abstracts. 2021; 1(01).
- Cousins KR. Computer review of Chem Draw Ultra 12.0. J Am Chem Soc. 2011; 133(21):8388. https://doi.org/10.1021/ ja204075s. PMid:21561109
- Usha T, Goyal AK, Lubna S, Prashanth HP, Mohan TM, Pande V, et al. Identification of anti-cancer targets of eco-friendly waste punica granatum peel by dual reverse virtual screening and binding analysis. Asian Pac J Cancer Prev. 2015; 15(23):10345–50. https://doi.org/10.7314/ APJCP.2014.15.23.10345. PMid:25556473
- Sarvagalla S, Singh VK, Ke Y-Y, Shiao H-Y, Lin W-H, Hsieh H-P, et al. Identification of ligand efficient, fragment-like hits from an HTS library: Structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity. J Comput Aided Mol Des. 2015; 29(1):89–100. https://doi.org/10.1007/s10822- 014-9807-2. PMid:25344840
- Geerts T, Vander Heyden Y. In Silico predictions of ADME-Tox properties: Drug absorption. Comb Chem High Throughput Screen. 2011; 14(5):339–61. https://doi. org/10.2174/138620711795508359. PMid:21470183
- Naresh P, Selvaraj A, Sundar PS, Murugesan S, Sathianarayanan S, Namboori PKK, et al. Targeting a conserved pocket (n-octyl-β-D-glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors. J Biomol Struct Dyn. 2020; 1–13. https://doi.org/10.1080/073 91102.2020.1862707. PMid:33345726
- Prabha T, Kapoor VK, Selvamani P, Latha S, Sivakumar T, Jubie S. Dual modulators of selected plant secondary metabolites targeting COVID-19 main protease and Interleukin-2: An in-silico approach based novel hypothesis. COVID. 2021; 2(2):223–34. https://doi.org/10.2174/2 666796701999200929124556